about
Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and managementDopamine Transporter SPECT Imaging in Corticobasal Syndrome.A molecular signature in blood identifies early Parkinson's disease.Current treatment and future prospects of dopa-induced dyskinesias.Gait dynamics in Pisa syndrome and Camptocormia: The role of stride length and hip kinematics.Neuroimaging in Parkinson's disease: focus on substantia nigra and nigro-striatal projection.High-Resolution 7T MR Imaging of the Motor Cortex in Amyotrophic Lateral Sclerosis.Mesolimbic dopaminergic dysfunction in Parkinson's disease depression: evidence from a 123I-FP-CIT SPECT investigation.Morphometric and functional MRI changes in essential tremor with and without resting tremor."Parkinson-dementia" diseases: a comparison by double tracer SPECT studies.The relationship between motor symptom lateralization and cognitive performance in newly diagnosed drug-naïve patients with Parkinson's disease.CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease.Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder.Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients.Nigral anatomy and striatal denervation in genetic Parkinsonism: A family report.Semiautomated Evaluation of the Primary Motor Cortex in Patients with Amyotrophic Lateral Sclerosis at 3T.Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.Bilateral thalamic glioma presenting with parkinsonism.Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction.Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI.Alexithymia is associated with depression in de novo Parkinson's disease.The association between motor subtypes and alexithymia in de novo Parkinson's disease.Symptomatic orthostatic tremor associated with Graves' disease.Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.A pilot psychometric study of aberrant salience state in patients with Parkinson's disease and its association with dopamine replacement therapy.Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.Parkinson's disease and pathological gambling: results from a functional MRI study.Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders.[¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism.Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.Social Cognition and Oxytocin in Huntington's Disease: New InsightsMR Imaging of the Substantia Nigra at 7 T Enables Diagnosis of Parkinson DiseaseShort-term side-effects of brain MR examination at 7 T: a single-centre experienceNeuropathy and levodopa in Parkinson's disease: Evidence from a multicenter studyIowa gambling task in de novo Parkinson's disease: A comparison between good and poor performersMild cognitive impairment in De Novo Parkinson's disease according to movement disorder guidelinesImpulsivity Is Associated With Decision-Making Deficits in De-Novo Parkinson's Disease
P50
Q28272063-8EE6C2EF-BAC6-4B69-8491-2383F98458D9Q33894779-B78E713A-5DDD-44CB-88B6-1032409201BFQ36179021-14FCA8AE-1105-4C2E-BD65-386BE69E3352Q38534096-59265159-39B3-4104-A6CE-D5720CAA9653Q38721451-4501D249-1ED5-4DBA-9606-78949DC4A4CBQ39326261-E4D96948-9717-42EC-BA6A-23D633D71FC8Q40198465-4EC6F463-A70B-4EA2-A849-D1E49F8DFA1BQ41542164-E3006650-BE1A-47F8-88FE-3F771FAEFDC7Q41604063-16C27F73-1AEC-4526-813A-D620FDAD18A1Q44283053-817BB94B-79DE-4D3F-8B1C-FE1205523496Q45841445-7C312710-B7C4-4467-8D7B-BBFF3EBB241EQ46658851-29D60753-31D1-4900-9B66-36B328484E1EQ47700136-CC264E81-586C-43B5-9C61-4BA5D7C76ACDQ48034737-E9F2A5AB-7082-4756-9E2A-2394039BE980Q48118182-94074C59-6AC5-4AC8-8624-719C6F7A9FA9Q48331848-1BCF6EC6-9E11-420A-A43C-6D01C2F36FE9Q48463469-CE7112F0-389A-4F1F-A97F-F1712A625041Q48465167-9FED2B57-789D-4E6C-B66A-E05E6BD1029FQ48507834-F6D92396-AAE8-4EFA-88EE-24BB217A227BQ48593238-63CF33DF-A6D8-43F2-B483-A016ABEF1F4CQ48859301-080408F8-359D-4F4B-9B14-8770B9188D56Q48875491-3BDE6456-F2E6-47A1-8293-14FCC06B9CB0Q48941906-EA41D6C9-7490-476D-9D63-6412D39046F1Q50248222-C9650587-9CE5-4192-8504-BC5C2E313447Q50260006-5C19A71A-AE2D-4584-9816-E0280E525F19Q50633529-D6CD8829-8FD5-4647-9C0A-D162B2DF1281Q50669602-64C897F4-65F8-45E2-B198-0C7439FA763FQ51047922-5A9E37EA-FCE4-4253-8DC7-185646AEB58FQ51764708-0C9FFA29-D4E6-4010-BD53-91B9B3EC6417Q51897144-CDAAA918-C6D5-45FA-9A2D-82452A0FDFB0Q52573281-969C5094-8037-415D-874A-EF62E6811998Q53155325-2D9A8E41-BD51-4CEF-822D-DEE8F7D0EFCFQ53287838-16C8042B-0328-4D72-8506-522438F0E957Q58702029-2EBE372C-3242-4069-BBAC-A5E90CFAB127Q59339586-C380D909-214F-448C-A2F0-97BDF8252A5DQ59339595-C5A52751-AF72-4E09-BC81-BF05687B4B3BQ59339607-B273D782-0859-429B-81EA-1FFD03B6578BQ59339627-E163D006-54DD-41C0-8484-E3B775ECCEF8Q59339634-D15B3128-5437-4FA8-9586-C7275A4340C3Q59339654-0B3B2AFD-1241-4BBB-9F98-158E3C1B180C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniela Frosini
@ast
Daniela Frosini
@en
Daniela Frosini
@es
Daniela Frosini
@nl
Daniela Frosini
@sl
type
label
Daniela Frosini
@ast
Daniela Frosini
@en
Daniela Frosini
@es
Daniela Frosini
@nl
Daniela Frosini
@sl
prefLabel
Daniela Frosini
@ast
Daniela Frosini
@en
Daniela Frosini
@es
Daniela Frosini
@nl
Daniela Frosini
@sl
P1053
J-8015-2016
P106
P1153
24328997800
P21
P31
P3829
P496
0000-0002-4049-7424
P569
2000-01-01T00:00:00Z